Ferrantelli F - Search Results

1

SARS-CoV-2-Specific CD8⁺ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.

Ferrantelli F, Manfredi F, Chiozzini C, Leone P, Pugliese K, Spada M, Di Virgilio A, Giovannelli A, Valeri M, Cara A, Michelini Z, Andreotti M, Federico M. Ferrantelli F, et al. Vaccines (Basel). 2023 Aug 30;11(9):1433. doi: 10.3390/vaccines11091433. Vaccines (Basel). 2023. PMID: 37766110 Free PMC article.

2

N-Terminal Fatty Acids of NEF^MUT Are Required for the CD8⁺ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

Chiozzini C, Manfredi F, Arenaccio C, Ferrantelli F, Leone P, Federico M. Chiozzini C, et al. Among authors: ferrantelli f. Vaccines (Basel). 2020 May 22;8(2):243. doi: 10.3390/vaccines8020243. Vaccines (Basel). 2020. PMID: 32456079 Free PMC article.

3

Simultaneous CD8⁺ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs.

Ferrantelli F, Chiozzini C, Manfredi F, Giovannelli A, Leone P, Federico M. Ferrantelli F, et al. Vaccines (Basel). 2021 Mar 10;9(3):240. doi: 10.3390/vaccines9030240. Vaccines (Basel). 2021. PMID: 33801926 Free PMC article.

4

The C-Terminal Domain of Nef^mut Is Dispensable for the CD8⁺ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

Chiozzini C, Manfredi F, Ferrantelli F, Leone P, Giovannelli A, Olivetta E, Federico M. Chiozzini C, et al. Among authors: ferrantelli f. Vaccines (Basel). 2021 Apr 12;9(4):373. doi: 10.3390/vaccines9040373. Vaccines (Basel). 2021. PMID: 33921215 Free PMC article.

5

Strong SARS-CoV-2 N-Specific CD8⁺ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice.

Ferrantelli F, Chiozzini C, Manfredi F, Leone P, Spada M, Di Virgilio A, Giovannelli A, Sanchez M, Cara A, Michelini Z, Federico M. Ferrantelli F, et al. Viruses. 2022 Feb 6;14(2):329. doi: 10.3390/v14020329. Viruses. 2022. PMID: 35215922 Free PMC article.

6

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein.

Manfredi F, Chiozzini C, Ferrantelli F, Leone P, Giovannelli A, Sanchez M, Federico M. Manfredi F, et al. Among authors: ferrantelli f. Vaccines (Basel). 2022 Jun 30;10(7):1060. doi: 10.3390/vaccines10071060. Vaccines (Basel). 2022. PMID: 35891224 Free PMC article.

7

Antiviral effect of SARS-CoV-2 N-specific CD8⁺ T cells induced in lungs by engineered extracellular vesicles.

Manfredi F, Chiozzini C, Ferrantelli F, Leone P, Pugliese K, Spada M, Di Virgilio A, Giovannelli A, Valeri M, Cara A, Michelini Z, Andreotti M, Federico M. Manfredi F, et al. Among authors: ferrantelli f. NPJ Vaccines. 2023 Jun 2;8(1):83. doi: 10.1038/s41541-023-00686-y. NPJ Vaccines. 2023. PMID: 37268624 Free PMC article.

8

Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4⁺ T lymphocytes and reactivation of the HIV-1 reservoir.

Chiozzini C, Arenaccio C, Olivetta E, Anticoli S, Manfredi F, Ferrantelli F, d'Ettorre G, Schietroma I, Andreotti M, Federico M. Chiozzini C, et al. Among authors: ferrantelli f. Arch Virol. 2017 Sep;162(9):2565-2577. doi: 10.1007/s00705-017-3391-4. Epub 2017 May 4. Arch Virol. 2017. PMID: 28474225

9

Long-Term Antitumor CD8⁺ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.

Ferrantelli F, Manfredi F, Chiozzini C, Leone P, Giovannelli A, Olivetta E, Federico M. Ferrantelli F, et al. Cancers (Basel). 2021 May 8;13(9):2263. doi: 10.3390/cancers13092263. Cancers (Basel). 2021. PMID: 34066801 Free PMC article.

10

Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.

Anticoli S, Aricò E, Arenaccio C, Manfredi F, Chiozzini C, Olivetta E, Ferrantelli F, Lattanzi L, D'Urso MT, Proietti E, Federico M. Anticoli S, et al. Among authors: ferrantelli f. J Mol Med (Berl). 2018 Feb;96(2):211-221. doi: 10.1007/s00109-017-1617-2. Epub 2017 Dec 27. J Mol Med (Berl). 2018. PMID: 29282521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page